Page 69 - Atouts Economiques Cameroun-2019-GB
P. 69

                Onchocerciasis, Lymphatic Filariasis
For the year 2016, more than 10.5 million peo- ple were exposed to onchocerciasis, of whom 9 970 061 were at risk. Therapeutic coverage in hyper/meso-endemic areas involved 8,115,413 people, a rate of 81.4%.
With regard to lymphatic filariasis, more than 15 million people were exposed, of whom 14,579,238 were at risk. Therapeutic coverage in hyper/meso-endemic areas involved 11,731,749 people, that is to say a rate of 80.3%. In the 1,758 communities under treat- ment, 1,789 suspected cases of hydroceles and 655 elephantiasis were notified.
To treat these diseases, 32, 919, 500 Mectizan tablets and 12, 358, 200 Albendazole were distributed. In addition, 2577 health workers and 57,509 community distributors were trained or retrained.
In 2016, immunization coverage with DTP-HEP B + HIB3 moved from 84% in 2015 to 83%; those of the tracer antigens, which are Penta3 and measles vaccine, were 82% and 78%, respectively.
Epidemiological surveillance investigated 788 cases of acute flaccid paralysis, 1 652 cases of
Evolution of coverage in
measles, 3 009 cases of yellow fever. No case of wild poliovirus or poliovirus derived from a cir- culating vaccine strain was detected. In addition, a yellow fever epidemic has been confirmed in 12 health districts.
In the first half of 2017, vaccine coverage for the Penta3 tracer antigens and measles vaccine anti- gens is 82% and 75% respectively.
In 2016, the strengthening of the infrastructure supply and the equipping of health facilities conti- nued with the construction of 92 integrated health centres, 4 medical centres of districts, 3 mothers/children wings and 8 fences in the health centres; the rehabilitation of 8 district medical centres; the equipping of 116 integra- ted health centres, 18 district medical centres and 2 mothers/children wings as part of the decentralization process.
Other actions that have been carried out are; the improvement of imaging platforms in the general hospitals of Douala and Yaoundé, as well as that of the gynaecological-obstetrics and paediatric hospital in Yaoundé; the renewal of imaging equipment (scanner) at the gynaecological-obste- trics and pediatric hospital in Douala; the com- pletion and commissioning of a new wing at
the immunization Cameroon (in %)
 ANTIGENES 2013 2014
2015 2016 2017*
74 70 96
83 83 80
79 78 75
60 58 69
77 78 76
84 85 82
63 68 79
73 79 80
82 74
88 79
83 80
62 64
83 80
89 87
- -
- -
            Source : MINSANTE - : VAR=measles; VAT2+=pregnant women anti-tetanus vaccination; VAA= yellow fever; PENTA3= combination of several antigens (hepatitis B-Hib-DTC3) *1st half-year
Laquintinie Hospital in Douala; the renewal of the technical equipment of the regional hospitals of Bafoussam, Bamenda, Bertoua, Ebolowa, Ngaoundere, Garoua and Maroua, as well as those of the annexes of Edéa, Limbe, Buea, Nkonsamba, Ayos, Kousseri and Yagoua.
In addition, the Yaoundé Military Hospital has been equipped with a state-of-the-art magne- tic resonance imaging (MRI) device. The follo- wing works are in progress: the construction of
8 regional hospitals in the headquarters of regions other than Yaoundé and Douala; the rehabilitation of the Yaoundé University Hospital Centre and the general hospitals of Douala and Yaoundé; the construction of 48 integrated health centres, 6 medical centres of districts and 4 mothers/children wings; the equipping of 113 integrated health centres and 19 district medical centres; the construction of a General Hospital in Garoua, funded by South Korea.

   67   68   69   70   71